At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02500 VENUS MEDTECH-B
Closed New Year's Day 12-31 12:08:27
2.380
-0.050
-2.06%
High2.500
Low2.380
Vol863.00K
Open2.430
D1 Closing2.430
Amplitude4.94%
Mkt Cap1.05B
Tradable Cap1.05B
Total Shares441.01M
T/O2.08M
T/O Rate0.20%
Tradable Shares441.01M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
BRIEF-Venus Medtech Hangzhou To Sell 157,800 Series B Preferred Shares Of Valgen Holding
HK Stock Movement | VENUS MEDTECH-B (02500) Rises Over 7% as Cardiovalve Tricuspid Valve Replacement System Shows Positive Mid-Term Clinical Safety and Efficacy
Venus Medtech Hangzhou Inc is a China-based company principally engaged in the research and development, and the manufacture and sale of bioprosthetic heart valves. The Company mainly engages in minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company provides interventional heart valve devices for valvular heart disease including aortic valve, pulmonic valve, mitral valve and tricuspid valve, a radio frequency ablation system for interventional treatment of HCM, a renal artery denervation ultrasound ablation system for interventional treatment of hypertension and other accessory consumables. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8/TAV8 and TriGUARD3 Cerebral Embolic Protection Device. The Company mainly conducts its businesses in the domestic market and overseas markets.